1. Home
  2. BBLG vs VRAX Comparison

BBLG vs VRAX Comparison

Compare BBLG & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBLG

Bone Biologics Corp

N/A

Current Price

$2.11

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.47

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBLG
VRAX
Founded
2004
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BBLG
VRAX
Price
$2.11
$0.47
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
37.6K
15.3M
Earning Date
11-14-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.35
52 Week High
$7.74
$3.20

Technical Indicators

Market Signals
Indicator
BBLG
VRAX
Relative Strength Index (RSI) 64.95 46.82
Support Level $1.47 $0.39
Resistance Level $1.99 $0.87
Average True Range (ATR) 0.17 0.07
MACD 0.09 0.02
Stochastic Oscillator 93.02 23.13

Price Performance

Historical Comparison
BBLG
VRAX

About BBLG Bone Biologics Corp

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: